BioReference Laboratories and Parent Company

MA 2022 Physician Practices

DOJ False Claims Act Anti Kickback

Penalty

$9.8 million

Outcome

BioReference Laboratories and Parent Company Agree to Pay $9.85 Million to Resolve False Claims Act Allegations of Illegal Payments to Referring Physicians

Details

BioReference Laboratories and Parent Company — DOJ Enforcement (2022)

Outcome: BioReference Laboratories and Parent Company Agree to Pay $9.85 Million to Resolve False Claims Act Allegations of Illegal Payments to Referring Physicians

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations.

Source: DOJ Press Release — BioReference Laboratories and Parent Company Agree to Pay $9.85 Million to Resolve False Claims Act Allegations of Illegal Payments to Referring Physi

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works